Bermekimab (MABp1) is a human monoclonal antibody designed to specifically target and neutralize interleukin-1 alpha (IL-1??). By inhibiting this cytokine, Bermekimab effectively reduces tumor-associated inflammation, offering potential therapeutic benefits in the management of cancer-related inflammatory processes.
Bermekimab (MABp1) is a human monoclonal antibody designed to specifically target and neutralize interleukin-1 alpha (IL-1??). By inhibiting this cytokine, Bermekimab effectively reduces tumor-associated inflammation, offering potential therapeutic benefits in the management of cancer-related inflammatory processes.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
